Stroke Centre, Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, Fulham Palace Road, London, W6 8RF, UK.
BMC Neurol. 2022 Nov 9;22(1):415. doi: 10.1186/s12883-022-02953-2.
The evidence for mechanical thrombectomy in acute basilar artery occlusion has until now remained inconclusive with basilar artery strokes associated with high rates of death and disability. This systematic review and meta-analysis will summarize the available evidence for the effectiveness of mechanical thrombectomy in acute basilar artery occlusion compared to best medical therapy.
We conducted a systematic review and meta-analysis of randomized controlled trials using Embase, Medline and the Cochrane Central Register of Controlled Trials (CENTRAL). We calculated risk ratios (RRs) and 95% confidence intervals (CIs) to summarize the effect estimates for each outcome.
We performed a random effects (Mantel-Haenszel) meta-analysis of the four included randomized controlled trials comprising a total of 988 participants. We found a statistically significant improvement in the rates of those with a good functional outcome (mRS 0-3, RR 1.54, 1.16-2.06, p = 0.003) and functional independence (mRS 0-2, RR 1.69, 1.05-2.71, p = 0.03) in those who were treated with thrombectomy when compared to best medical therapy alone. Thrombectomy was associated with a higher level of sICH (RR 7.12, 2.16-23.54, p = 0.001) but this was not reflected in a higher mortality rate, conversely the mortality rate was significantly lower in the intervention group (RR 0.76, 0.65-0.89, p = 0.0004).
Our meta-analysis of the recently presented randomized controlled studies is the first to confirm the disability and mortality benefit of mechanical thrombectomy in basilar artery stroke.
机械取栓治疗急性基底动脉闭塞的证据至今仍不确定,基底动脉卒中有很高的死亡率和残疾率。本系统评价和荟萃分析将总结机械取栓治疗急性基底动脉闭塞与最佳药物治疗相比的有效性证据。
我们使用 Embase、Medline 和 Cochrane 对照试验中心注册库(CENTRAL)进行了系统评价和荟萃分析。我们计算了风险比(RR)和 95%置信区间(CI)来总结每个结局的效应估计值。
我们对纳入的四项随机对照试验进行了随机效应(Mantel-Haenszel)荟萃分析,共纳入 988 名参与者。我们发现,与单独最佳药物治疗相比,机械取栓治疗可显著提高良好功能结局(mRS 0-3,RR 1.54,1.16-2.06,p=0.003)和功能独立性(mRS 0-2,RR 1.69,1.05-2.71,p=0.03)的比例。取栓治疗与更高的 sICH 发生率相关(RR 7.12,2.16-23.54,p=0.001),但这并未反映在更高的死亡率上,相反,干预组的死亡率显著降低(RR 0.76,0.65-0.89,p=0.0004)。
我们对最近发表的随机对照研究的荟萃分析首次证实了机械取栓治疗基底动脉卒中有改善残疾和降低死亡率的作用。